Market by Type, Application, End-user, and Country Outlook | Forecast 2021-2028
According to Triton Market Research,
the botulinum toxin market in Latin America is poised to proliferate with a
CAGR of 5.48% over the forecasting phase from 2021 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries considered in
this region are:
• Brazil
• Mexico
• Rest of Latin America countries
In Brazil, the rising adoption
of minimally invasive & non-invasive cosmetic procedures and the broad
range of indications with respect to botulinum toxin-based treatment are the
major market drivers. The brand names of botulinum toxin type A formulations
available in Brazil include Botox, Xeomin, Dysport, Botulift, and Prosigne. The
ISAPS has stated that, botulinum toxin-based treatment was the most common
non-surgical procedure performed in the country in 2018, procedures accounting
for 51% (approx. 392,530) of the total non-surgical procedures that year.
Moreover, Brazil is the second-most-popular country in the world, in terms of
botulinum toxin-based aesthetic procedures performed. All these factors have
enhanced the adoption of botulinum toxin-based aesthetic procedures.
In addition, the entry of key
players in the Brazilian market is expected to significantly impact the growth
prospects. For instance, Daewoong Pharmaceutical, in February 2020, received
approval from ANVISA for the usage and sale of the botulinum toxin type,
Nabota, in Brazil. Therefore, given the rising demand for botulinum toxin-based
non-invasive procedures and the introduction of botulinum toxin-based products
by reputed industry players are expected to foster the growth of the over the
botulinum toxin market forecast period.
Hugel Inc. is one of the most
prominent names in the aesthetics & therapeutics market. The company is
engaged in developing, manufacturing, and marketing biomedical products. It is
one of the global experts in the field of medical aesthetic solutions, with
products such as botulinum toxins, clinical derma cosmetics, HA fillers, and
others. The company’s subsidiaries include Hugel America Inc, Across Co Ltd,
Croma Aesthetics Canada Ltd, Croma Australia Pty Ltd, Weihai Hugel Pharma Co
Ltd, and Hugel Pharma (Vietnam) Co Ltd. Hugel has a global network, with
partners spread across more than 40 countries. The company’s botulinum toxin is
marketed in 27 countries, including Brazil, Chile, Colombia, Panama, Ecuador,
Peru, Uruguay, Bolivia, Paraguay, Honduras, Costa Rica, El Salvador, Guatemala,
and the Dominican Republic.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT1. LATIN
AMERICA BOTULINUM TOXIN MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. KEY
INSIGHTS
2.1.1. SURGE
IN DISPOSABLE INCOME
2.1.2. GROWING
NUMBER OF MEN OPTING FOR COSMETIC TREATMENT
2.1.3. DEVELOPMENT
OF HEALTHCARE INFRASTRUCTURE
2.2. IMPACT
OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS MATRIX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. NEW
PRODUCT LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. INCREASING
DEMAND FOR AESTHETIC PROCEDURES
2.7.2. EXPANSION
OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
2.8. MARKET
RESTRAINTS
2.8.1. ADVERSE
EFFECTS ASSOCIATED WITH BOTULINUM TOXIN
2.8.2. LACK
OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
2.8.3. LACK
OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASING
AGING POPULATION
2.9.2. RISE
IN MEDICAL TOURISM
3. LATIN
AMERICA BOTULINUM TOXIN MARKET – BY TYPE
3.1. TYPE A
3.2. TYPE B
4. LATIN
AMERICA BOTULINUM TOXIN MARKET – BY APPLICATION
4.1. COSMETIC
APPLICATIONS
4.1.1. GLABELLAR
LINES
4.1.2. LATERAL
CANTHAL LINES (CROW’S FEET)
4.1.3. FOREHEAD
LINES
4.1.4. OTHER
COSMETIC APPLICATIONS
4.2. NON-COSMETIC
APPLICATIONS
4.2.1. DYSTONIA
4.2.2. CHRONIC
MIGRAINE
4.2.3. OPHTHALMOLOGIC
DISORDERS
4.2.4. OTHER
NON-COSMETIC APPLICATIONS
5. LATIN
AMERICA BOTULINUM TOXIN MARKET – BY END-USER
5.1. HOSPITALS
5.2. CLINICS
AND OTHERS
6. LATIN
AMERICA BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK
6.1. COUNTRY
ANALYSIS
6.1.1. BRAZIL
6.1.2. MEXICO
6.1.3. REST
OF LATIN AMERICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBVIE
INC
7.2. EVOLUS
INC
7.3. GALDERMA
PHARMA SA (ACQUIRED BY EQT)
7.4. HUGEL
INC
7.5. IPSEN
PHARMA
7.6. MERZ
PHARMA
7.7. MEDYTOX
INC
7.8. REVANCE
THERAPEUTICS INC
7.9. US
WORLDMEDS LLC
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS
MATRIX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF NEW PRODUCT
LAUNCHES
TABLE 5: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 10: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE 3: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 6: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $
MILLION)
FIGURE 9: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $
MILLION)
FIGURE 11: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $
MILLION)
FIGURE 16: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE 17: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 18: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 19: LATIN AMERICA
BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 20: BRAZIL BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: MEXICO BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: REST OF LATIN
AMERICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)